img

Global Integrin Alpha 4 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Integrin Alpha 4 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Integrin Alpha 4 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Integrin Alpha 4 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Acute Ischemic Stroke and Celiac Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Integrin Alpha 4 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Integrin Alpha 4 key manufacturers include Amgen Inc, Antisense Therapeutics Ltd, Biogen Inc, BioMAS Ltd, Daiichi Sankyo Co Ltd, EA Pharma Co Ltd, Immunwork Inc, Morphic Therapeutic Inc and Protagonist Therapeutics Inc, etc. Amgen Inc, Antisense Therapeutics Ltd, Biogen Inc are top 3 players and held % sales share in total in 2022.
Integrin Alpha 4 can be divided into TE-5232, ATL-1102, Carotegrast and ET-3764, etc. TE-5232 is the mainstream product in the market, accounting for % sales share globally in 2022.
Integrin Alpha 4 is widely used in various fields, such as Acute Ischemic Stroke, Celiac Disease, Epilepsy and Melanoma, etc. Acute Ischemic Stroke provides greatest supports to the Integrin Alpha 4 industry development. In 2022, global % sales of Integrin Alpha 4 went into Acute Ischemic Stroke filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Integrin Alpha 4 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen Inc
Antisense Therapeutics Ltd
Biogen Inc
BioMAS Ltd
Daiichi Sankyo Co Ltd
EA Pharma Co Ltd
Immunwork Inc
Morphic Therapeutic Inc
Protagonist Therapeutics Inc
Takeda Pharmaceutical Co Ltd
Viriom Inc
Segment by Type
TE-5232
ATL-1102
Carotegrast
ET-3764
Others

Segment by Application


Acute Ischemic Stroke
Celiac Disease
Epilepsy
Melanoma
Multiple Sclerosis
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Integrin Alpha 4 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Integrin Alpha 4, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Integrin Alpha 4 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Integrin Alpha 4 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Integrin Alpha 4 introduction, etc. Integrin Alpha 4 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Integrin Alpha 4 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Integrin Alpha 4 Market Overview
1.1 Integrin Alpha 4 Product Overview
1.2 Integrin Alpha 4 Market Segment by Type
1.2.1 TE-5232
1.2.2 ATL-1102
1.2.3 Carotegrast
1.2.4 ET-3764
1.2.5 Others
1.3 Global Integrin Alpha 4 Market Size by Type
1.3.1 Global Integrin Alpha 4 Market Size Overview by Type (2018-2034)
1.3.2 Global Integrin Alpha 4 Historic Market Size Review by Type (2018-2024)
1.3.3 Global Integrin Alpha 4 Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Integrin Alpha 4 Sales Breakdown by Type (2018-2024)
1.4.2 Europe Integrin Alpha 4 Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Integrin Alpha 4 Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Integrin Alpha 4 Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Integrin Alpha 4 Sales Breakdown by Type (2018-2024)
2 Global Integrin Alpha 4 Market Competition by Company
2.1 Global Top Players by Integrin Alpha 4 Sales (2018-2024)
2.2 Global Top Players by Integrin Alpha 4 Revenue (2018-2024)
2.3 Global Top Players by Integrin Alpha 4 Price (2018-2024)
2.4 Global Top Manufacturers Integrin Alpha 4 Manufacturing Base Distribution, Sales Area, Product Type
2.5 Integrin Alpha 4 Market Competitive Situation and Trends
2.5.1 Integrin Alpha 4 Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Integrin Alpha 4 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Integrin Alpha 4 as of 2022)
2.7 Date of Key Manufacturers Enter into Integrin Alpha 4 Market
2.8 Key Manufacturers Integrin Alpha 4 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Integrin Alpha 4 Status and Outlook by Region
3.1 Global Integrin Alpha 4 Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Integrin Alpha 4 Historic Market Size by Region
3.2.1 Global Integrin Alpha 4 Sales in Volume by Region (2018-2024)
3.2.2 Global Integrin Alpha 4 Sales in Value by Region (2018-2024)
3.2.3 Global Integrin Alpha 4 Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Integrin Alpha 4 Forecasted Market Size by Region
3.3.1 Global Integrin Alpha 4 Sales in Volume by Region (2024-2034)
3.3.2 Global Integrin Alpha 4 Sales in Value by Region (2024-2034)
3.3.3 Global Integrin Alpha 4 Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Integrin Alpha 4 by Application
4.1 Integrin Alpha 4 Market Segment by Application
4.1.1 Acute Ischemic Stroke
4.1.2 Celiac Disease
4.1.3 Epilepsy
4.1.4 Melanoma
4.1.5 Multiple Sclerosis
4.1.6 Other
4.2 Global Integrin Alpha 4 Market Size by Application
4.2.1 Global Integrin Alpha 4 Market Size Overview by Application (2018-2034)
4.2.2 Global Integrin Alpha 4 Historic Market Size Review by Application (2018-2024)
4.2.3 Global Integrin Alpha 4 Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Integrin Alpha 4 Sales Breakdown by Application (2018-2024)
4.3.2 Europe Integrin Alpha 4 Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Integrin Alpha 4 Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Integrin Alpha 4 Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Integrin Alpha 4 Sales Breakdown by Application (2018-2024)
5 North America Integrin Alpha 4 by Country
5.1 North America Integrin Alpha 4 Historic Market Size by Country
5.1.1 North America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Integrin Alpha 4 Sales in Volume by Country (2018-2024)
5.1.3 North America Integrin Alpha 4 Sales in Value by Country (2018-2024)
5.2 North America Integrin Alpha 4 Forecasted Market Size by Country
5.2.1 North America Integrin Alpha 4 Sales in Volume by Country (2024-2034)
5.2.2 North America Integrin Alpha 4 Sales in Value by Country (2024-2034)
6 Europe Integrin Alpha 4 by Country
6.1 Europe Integrin Alpha 4 Historic Market Size by Country
6.1.1 Europe Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Integrin Alpha 4 Sales in Volume by Country (2018-2024)
6.1.3 Europe Integrin Alpha 4 Sales in Value by Country (2018-2024)
6.2 Europe Integrin Alpha 4 Forecasted Market Size by Country
6.2.1 Europe Integrin Alpha 4 Sales in Volume by Country (2024-2034)
6.2.2 Europe Integrin Alpha 4 Sales in Value by Country (2024-2034)
7 Asia-Pacific Integrin Alpha 4 by Region
7.1 Asia-Pacific Integrin Alpha 4 Historic Market Size by Region
7.1.1 Asia-Pacific Integrin Alpha 4 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Integrin Alpha 4 Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Integrin Alpha 4 Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Integrin Alpha 4 Forecasted Market Size by Region
7.2.1 Asia-Pacific Integrin Alpha 4 Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Integrin Alpha 4 Sales in Value by Region (2024-2034)
8 Latin America Integrin Alpha 4 by Country
8.1 Latin America Integrin Alpha 4 Historic Market Size by Country
8.1.1 Latin America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Integrin Alpha 4 Sales in Volume by Country (2018-2024)
8.1.3 Latin America Integrin Alpha 4 Sales in Value by Country (2018-2024)
8.2 Latin America Integrin Alpha 4 Forecasted Market Size by Country
8.2.1 Latin America Integrin Alpha 4 Sales in Volume by Country (2024-2034)
8.2.2 Latin America Integrin Alpha 4 Sales in Value by Country (2024-2034)
9 Middle East and Africa Integrin Alpha 4 by Country
9.1 Middle East and Africa Integrin Alpha 4 Historic Market Size by Country
9.1.1 Middle East and Africa Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Integrin Alpha 4 Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Integrin Alpha 4 Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Integrin Alpha 4 Forecasted Market Size by Country
9.2.1 Middle East and Africa Integrin Alpha 4 Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Integrin Alpha 4 Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Amgen Inc
10.1.1 Amgen Inc Company Information
10.1.2 Amgen Inc Introduction and Business Overview
10.1.3 Amgen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen Inc Integrin Alpha 4 Products Offered
10.1.5 Amgen Inc Recent Development
10.2 Antisense Therapeutics Ltd
10.2.1 Antisense Therapeutics Ltd Company Information
10.2.2 Antisense Therapeutics Ltd Introduction and Business Overview
10.2.3 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Antisense Therapeutics Ltd Integrin Alpha 4 Products Offered
10.2.5 Antisense Therapeutics Ltd Recent Development
10.3 Biogen Inc
10.3.1 Biogen Inc Company Information
10.3.2 Biogen Inc Introduction and Business Overview
10.3.3 Biogen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biogen Inc Integrin Alpha 4 Products Offered
10.3.5 Biogen Inc Recent Development
10.4 BioMAS Ltd
10.4.1 BioMAS Ltd Company Information
10.4.2 BioMAS Ltd Introduction and Business Overview
10.4.3 BioMAS Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.4.4 BioMAS Ltd Integrin Alpha 4 Products Offered
10.4.5 BioMAS Ltd Recent Development
10.5 Daiichi Sankyo Co Ltd
10.5.1 Daiichi Sankyo Co Ltd Company Information
10.5.2 Daiichi Sankyo Co Ltd Introduction and Business Overview
10.5.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Products Offered
10.5.5 Daiichi Sankyo Co Ltd Recent Development
10.6 EA Pharma Co Ltd
10.6.1 EA Pharma Co Ltd Company Information
10.6.2 EA Pharma Co Ltd Introduction and Business Overview
10.6.3 EA Pharma Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.6.4 EA Pharma Co Ltd Integrin Alpha 4 Products Offered
10.6.5 EA Pharma Co Ltd Recent Development
10.7 Immunwork Inc
10.7.1 Immunwork Inc Company Information
10.7.2 Immunwork Inc Introduction and Business Overview
10.7.3 Immunwork Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Immunwork Inc Integrin Alpha 4 Products Offered
10.7.5 Immunwork Inc Recent Development
10.8 Morphic Therapeutic Inc
10.8.1 Morphic Therapeutic Inc Company Information
10.8.2 Morphic Therapeutic Inc Introduction and Business Overview
10.8.3 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Morphic Therapeutic Inc Integrin Alpha 4 Products Offered
10.8.5 Morphic Therapeutic Inc Recent Development
10.9 Protagonist Therapeutics Inc
10.9.1 Protagonist Therapeutics Inc Company Information
10.9.2 Protagonist Therapeutics Inc Introduction and Business Overview
10.9.3 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Protagonist Therapeutics Inc Integrin Alpha 4 Products Offered
10.9.5 Protagonist Therapeutics Inc Recent Development
10.10 Takeda Pharmaceutical Co Ltd
10.10.1 Takeda Pharmaceutical Co Ltd Company Information
10.10.2 Takeda Pharmaceutical Co Ltd Introduction and Business Overview
10.10.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Products Offered
10.10.5 Takeda Pharmaceutical Co Ltd Recent Development
10.11 Viriom Inc
10.11.1 Viriom Inc Company Information
10.11.2 Viriom Inc Introduction and Business Overview
10.11.3 Viriom Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Viriom Inc Integrin Alpha 4 Products Offered
10.11.5 Viriom Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Integrin Alpha 4 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Integrin Alpha 4 Industrial Chain Analysis
11.4 Integrin Alpha 4 Market Dynamics
11.4.1 Integrin Alpha 4 Industry Trends
11.4.2 Integrin Alpha 4 Market Drivers
11.4.3 Integrin Alpha 4 Market Challenges
11.4.4 Integrin Alpha 4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Integrin Alpha 4 Distributors
12.3 Integrin Alpha 4 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of TE-5232
Table 2. Major Company of ATL-1102
Table 3. Major Company of Carotegrast
Table 4. Major Company of ET-3764
Table 5. Major Company of Others
Table 6. Global Integrin Alpha 4 Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Integrin Alpha 4 Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Integrin Alpha 4 Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Integrin Alpha 4 Sales by Type (2018-2024) & (US& Million)
Table 10. Global Integrin Alpha 4 Market Share in Value by Type (2018-2024)
Table 11. Global Integrin Alpha 4 Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Integrin Alpha 4 Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Integrin Alpha 4 Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Integrin Alpha 4 Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Integrin Alpha 4 Sales Market Share in Value by Type (2024-2034)
Table 16. Global Integrin Alpha 4 Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Integrin Alpha 4 Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Integrin Alpha 4 Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Integrin Alpha 4 Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Integrin Alpha 4 Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Integrin Alpha 4 Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Integrin Alpha 4 Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Integrin Alpha 4 Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Integrin Alpha 4 Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Integrin Alpha 4 Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Integrin Alpha 4 Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Integrin Alpha 4 Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Integrin Alpha 4 Sales Share by Company (2018-2024)
Table 29. Global Integrin Alpha 4 Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Integrin Alpha 4 Revenue Share by Company (2018-2024)
Table 31. Global Market Integrin Alpha 4 Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Integrin Alpha 4 Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Integrin Alpha 4 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Integrin Alpha 4 as of 2022)
Table 35. Date of Key Manufacturers Enter into Integrin Alpha 4 Market
Table 36. Key Manufacturers Integrin Alpha 4 Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Integrin Alpha 4 Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Integrin Alpha 4 Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Integrin Alpha 4 Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Integrin Alpha 4 Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Integrin Alpha 4 Sales Market Share in Value by Region (2018-2024)
Table 43. Global Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Integrin Alpha 4 Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Integrin Alpha 4 Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Integrin Alpha 4 Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Integrin Alpha 4 Sales Market Share in Value by Region (2024-2034)
Table 48. Global Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Integrin Alpha 4 Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Integrin Alpha 4 Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Integrin Alpha 4 Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Integrin Alpha 4 Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Integrin Alpha 4 Sales Market Share in Value by Application (2018-2024)
Table 54. Global Integrin Alpha 4 Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Integrin Alpha 4 Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Integrin Alpha 4 Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Integrin Alpha 4 Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Integrin Alpha 4 Sales Market Share in Value by Application (2024-2034)
Table 59. Global Integrin Alpha 4 Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Integrin Alpha 4 Sales by Application (2018-2024) (K Pcs)
Table 61. North America Integrin Alpha 4 Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Integrin Alpha 4 Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Integrin Alpha 4 Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Integrin Alpha 4 Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Integrin Alpha 4 Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Integrin Alpha 4 Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Integrin Alpha 4 Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Integrin Alpha 4 Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Integrin Alpha 4 Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Integrin Alpha 4 Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Integrin Alpha 4 Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Integrin Alpha 4 Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Integrin Alpha 4 Sales Market Share in Value by Country (2018-2024)
Table 74. North America Integrin Alpha 4 Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Integrin Alpha 4 Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Integrin Alpha 4 Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Integrin Alpha 4 Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Integrin Alpha 4 Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Integrin Alpha 4 Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Integrin Alpha 4 Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Integrin Alpha 4 Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Integrin Alpha 4 Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Integrin Alpha 4 Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Integrin Alpha 4 Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Integrin Alpha 4 Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Integrin Alpha 4 Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Integrin Alpha 4 Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Integrin Alpha 4 Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Integrin Alpha 4 Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Integrin Alpha 4 Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Integrin Alpha 4 Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Integrin Alpha 4 Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Integrin Alpha 4 Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Integrin Alpha 4 Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Integrin Alpha 4 Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Integrin Alpha 4 Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Integrin Alpha 4 Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Integrin Alpha 4 Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Integrin Alpha 4 Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Integrin Alpha 4 Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Integrin Alpha 4 Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Integrin Alpha 4 Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Integrin Alpha 4 Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Integrin Alpha 4 Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Integrin Alpha 4 Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Integrin Alpha 4 Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Integrin Alpha 4 Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Integrin Alpha 4 Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Integrin Alpha 4 Sales Market Share in Value by Country (2024-2034)
Table 110. Amgen Inc Company Information
Table 111. Amgen Inc Introduction and Business Overview
Table 112. Amgen Inc Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Amgen Inc Integrin Alpha 4 Product
Table 114. Amgen Inc Recent Development
Table 115. Antisense Therapeutics Ltd Company Information
Table 116. Antisense Therapeutics Ltd Introduction and Business Overview
Table 117. Antisense Therapeutics Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Antisense Therapeutics Ltd Integrin Alpha 4 Product
Table 119. Antisense Therapeutics Ltd Recent Development
Table 120. Biogen Inc Company Information
Table 121. Biogen Inc Introduction and Business Overview
Table 122. Biogen Inc Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Biogen Inc Integrin Alpha 4 Product
Table 124. Biogen Inc Recent Development
Table 125. BioMAS Ltd Company Information
Table 126. BioMAS Ltd Introduction and Business Overview
Table 127. BioMAS Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. BioMAS Ltd Integrin Alpha 4 Product
Table 129. BioMAS Ltd Recent Development
Table 130. Daiichi Sankyo Co Ltd Company Information
Table 131. Daiichi Sankyo Co Ltd Introduction and Business Overview
Table 132. Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Daiichi Sankyo Co Ltd Integrin Alpha 4 Product
Table 134. Daiichi Sankyo Co Ltd Recent Development
Table 135. EA Pharma Co Ltd Company Information
Table 136. EA Pharma Co Ltd Introduction and Business Overview
Table 137. EA Pharma Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. EA Pharma Co Ltd Integrin Alpha 4 Product
Table 139. EA Pharma Co Ltd Recent Development
Table 140. Immunwork Inc Company Information
Table 141. Immunwork Inc Introduction and Business Overview
Table 142. Immunwork Inc Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Immunwork Inc Integrin Alpha 4 Product
Table 144. Immunwork Inc Recent Development
Table 145. Morphic Therapeutic Inc Company Information
Table 146. Morphic Therapeutic Inc Introduction and Business Overview
Table 147. Morphic Therapeutic Inc Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Morphic Therapeutic Inc Integrin Alpha 4 Product
Table 149. Morphic Therapeutic Inc Recent Development
Table 150. Protagonist Therapeutics Inc Company Information
Table 151. Protagonist Therapeutics Inc Introduction and Business Overview
Table 152. Protagonist Therapeutics Inc Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Protagonist Therapeutics Inc Integrin Alpha 4 Product
Table 154. Protagonist Therapeutics Inc Recent Development
Table 155. Takeda Pharmaceutical Co Ltd Company Information
Table 156. Takeda Pharmaceutical Co Ltd Introduction and Business Overview
Table 157. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product
Table 159. Takeda Pharmaceutical Co Ltd Recent Development
Table 160. Viriom Inc Company Information
Table 161. Viriom Inc Introduction and Business Overview
Table 162. Viriom Inc Integrin Alpha 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Viriom Inc Integrin Alpha 4 Product
Table 164. Viriom Inc Recent Development
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Integrin Alpha 4 Market Trends
Table 168. Integrin Alpha 4 Market Drivers
Table 169. Integrin Alpha 4 Market Challenges
Table 170. Integrin Alpha 4 Market Restraints
Table 171. Integrin Alpha 4 Distributors List
Table 172. Integrin Alpha 4 Downstream Customers
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Integrin Alpha 4 Product Picture
Figure 2. Global Integrin Alpha 4 Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Integrin Alpha 4 Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Integrin Alpha 4 Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of TE-5232
Figure 6. Global TE-5232 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of ATL-1102
Figure 8. Global ATL-1102 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Carotegrast
Figure 10. Global Carotegrast Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of ET-3764
Figure 12. Global ET-3764 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Integrin Alpha 4 Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Integrin Alpha 4 Sales Market Share by Type in 2022 & 2034
Figure 17. North America Integrin Alpha 4 Sales Market Share in Volume by Type in 2022
Figure 18. North America Integrin Alpha 4 Sales Market Share in Value by Type in 2022
Figure 19. Europe Integrin Alpha 4 Sales Market Share in Volume by Type in 2022
Figure 20. Europe Integrin Alpha 4 Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Integrin Alpha 4 Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Integrin Alpha 4 Sales Market Share in Value by Type in 2022
Figure 23. Latin America Integrin Alpha 4 Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Integrin Alpha 4 Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Integrin Alpha 4 Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Integrin Alpha 4 Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Integrin Alpha 4 Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Integrin Alpha 4 Revenue in 2022
Figure 29. Integrin Alpha 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Acute Ischemic Stroke
Figure 31. Global Acute Ischemic Stroke Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Celiac Disease
Figure 33. Global Celiac Disease Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Epilepsy
Figure 35. Global Epilepsy Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Melanoma
Figure 37. Global Melanoma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Multiple Sclerosis
Figure 39. Global Multiple Sclerosis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Product Picture of Other
Figure 41. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Global Integrin Alpha 4 Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Integrin Alpha 4 Sales Market Share by Application in 2022 & 2034
Figure 44. North America Integrin Alpha 4 Sales Market Share in Volume by Application in 2022
Figure 45. North America Integrin Alpha 4 Sales Market Share in Value by Application in 2022
Figure 46. Europe Integrin Alpha 4 Sales Market Share in Volume by Application in 2022
Figure 47. Europe Integrin Alpha 4 Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Integrin Alpha 4 Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Integrin Alpha 4 Sales Market Share in Value by Application in 2022
Figure 50. Latin America Integrin Alpha 4 Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Integrin Alpha 4 Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Integrin Alpha 4 Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Integrin Alpha 4 Manufacturing Cost Structure
Figure 55. Integrin Alpha 4 Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed